Home > Healthcare > Medical Devices > Therapeutic Devices > Linear Particle Accelerators Market

Linear Particle Accelerators Market Trends

Report ID: GMI9664
Published Date: May 2024
Report Format: PDF

Download Free Sample

Linear Particle Accelerators Market Trends

Vendors are increasingly focusing on the integration of cutting-edge imaging techniques such as magnetic resonance imaging, computed tomography, and positron emission tomography with linear particle accelerators. Such integrations enable real time visualization of tumors through image guided radiotherapy. For example, prostate-specific membrane antigen (PSMA) positron emission tomography (PET), imaging for prostate cancer, is an emerging technology that is anticipated to greatly enhance the detection and treatment of prostate cancer.
Linear particle accelerators are also finding increasing adoption in treatment of re-occurring cancers and in palliative care to manage symptoms and to improve quality of life of the patient.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The linear particle accelerators market size was valued at USD 2.8 billion in 2023 and is anticipated to showcase growth at 5.9% CAGR from 2024 – 2032, owing to the growing demand for radiotherapy treatments, and increasing awareness towards early cancer diagnosis.

The high energy machine segment in the market is anticipated to grow at 6.3% CAGR through 2032, attributed to their prevalent use for treating a wide range of cancers that are in deep seated areas.

North America linear particle accelerators market accounted for 41.1% share in 2023 and is predicted to reach USD 1.8 billion by 2032, attributed to the increasing demand for radiotherapy treatment.

AccSys Technology, Inc., Accuray Incorporated, Altair Technologies, Inc., Brainlab AG, Carl Zeiss Meditec AG, Elekta, Laird Technologies, MITSUBISHI HEAVY INDUSTRIES, LTD., Panacea Medical Technologies Pvt. Ltd., S.I.T. Sordina IORT Technologies S.p.A., and SHINVA MEDICAL INSTRUMENT CO., LTD.